about
Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific mannerIntegrin activation and focal complex formation in cardiac hypertrophy.c-Raf/MEK/ERK pathway controls protein kinase C-mediated p70S6K activation in adult cardiac muscle cells.Expression of protein kinase C isoforms in cultured human retinal pigment epithelial cells.Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor.Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolines.STAT3 activation in pressure-overloaded feline myocardium: role for integrins and the tyrosine kinase BMXKINOMIC ALTERATIONS IN ATYPICAL MENINGIOMA.Kinase control of latent HIV-1 infection: PIM-1 kinase as a major contributor to HIV-1 reactivation.Mini-review: bmx kinase inhibitors for cancer therapy.Fibroblast growth factor receptors as therapeutic targets in clear-cell renal cell carcinoma.Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease.Kinomic profiling approach identifies Trk as a novel radiation modulator.Differential efficacy of combined therapy with radiation and AEE788 in high and low EGFR-expressing androgen-independent prostate tumor models.Enzastaurin (LY317615), a protein kinase C beta selective inhibitor, enhances antiangiogenic effect of radiation.Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma.Bone marrow X kinase-mediated signal transduction in irradiated vascular endothelium.Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models.Focal complex formation in adult cardiomyocytes is accompanied by the activation of beta3 integrin and c-Src.A Phase II multi-institutional trial of chemoradiation using weekly docetaxel and erythropoietin for high-risk postoperative head and neck cancer patients.Inhibition of survivin and aurora B kinase sensitizes mesothelioma cells by enhancing mitotic arrests.Enhanced ubiquitination of cytoskeletal proteins in pressure overloaded myocardium is accompanied by changes in specific E3 ligases.Combinatorial Drug Testing in 3D Microtumors Derived from GBM Patient-Derived Xenografts Reveals Cytotoxic Synergy in Pharmacokinomics-informed Pathway Interactions.HIV protease inhibitors enhance the efficacy of irradiationNovel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancerSpleen Tyrosine Kinase-Mediated Autophagy Is Required for Epithelial-Mesenchymal Plasticity and Metastasis in Breast CancerA Novel Assay for Profiling GBM Cancer Model Heterogeneity and Drug Screening
P50
Q28740313-F4AE6BC6-B86A-490E-BFF1-8B3E29841384Q30910953-5BCAF186-12C7-4B4E-8D4D-5117E6FE4EB8Q31047994-4AD0E397-D27E-4D28-9737-B3DFA34DD478Q33264526-982F24C7-689F-4304-94F1-05263FAF395BQ33926261-34E86FC7-9EDF-465A-8A8F-F76B922421CBQ33992432-979D5B31-EC62-48FD-9F64-A92293B66744Q36743790-270A6FC3-6606-4A99-A333-FC105EC3C2F2Q36868537-56276432-54F5-4653-B6D9-E71117ACA2FAQ37547710-75B02F72-3415-4AA3-B569-4039E3DCFFDEQ38063917-E115AD6B-7399-45E9-871C-1CDEB7D0BF9AQ38175454-B7E0F6AD-33DC-4B08-9704-1FD90C9EDE95Q38242833-DA2406A5-83CC-4562-A79D-C6CABD47B7F3Q39353324-13D4A539-E690-4185-96C3-544E729E90C7Q39635478-8DC79445-1D57-4B84-B996-06CE41B190E5Q39776104-72E44634-2A2F-4BCB-8991-FC8628C1F064Q39823619-F12CCC13-9C34-459A-831A-CF25882B1AAEQ39991778-C92AEE87-8FA3-4D8B-BA9C-7E2B8671CE4BQ40132595-2ACBEADD-FDD8-4AEB-ACC3-865E8E846BF3Q44466706-C3B96A98-C085-4433-AF46-D3FFB51183C2Q51767338-8EF5A068-4F75-4CC1-8D5C-3BDF592AB1BEQ53562647-CC5740A7-EE70-422D-B454-25C947D2A885Q53603559-A946865F-E2C7-4AB2-9BD3-E7696BFD31BBQ54977613-D7FF8524-264B-49FF-B55D-C058B3DAA578Q80352297-4CB92CF6-6076-41A8-804F-C1CD97042389Q89759447-75E941A0-0D87-4C92-AF26-0D720212B9F2Q91408660-1AB120D6-9731-41E7-B60A-831D4ABA915AQ92127735-52E18A19-3ACA-4C51-A92F-088F95BDD350
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Christopher D Willey
@nl
Christopher D Willey
@sl
Christopher D. Willey
@en
Christopher D. Willey
@es
type
label
Christopher D Willey
@nl
Christopher D Willey
@sl
Christopher D. Willey
@en
Christopher D. Willey
@es
prefLabel
Christopher D Willey
@nl
Christopher D Willey
@sl
Christopher D. Willey
@en
Christopher D. Willey
@es
P106
P1153
16065003500
P21
P31
P496
0000-0001-9953-0279